Pharmacotherapy of Pain in Older Adults: Opioid and Adjuvant

作者: Mary Lynn McPherson , Tanya J. Uritsky

DOI: 10.1007/978-1-60761-618-4_8

关键词:

摘要: Opioids are naturally occurring, semisynthetic, and synthetic drugs whose effects mediated through opioid receptors, altering the perception emotional response to painful stimuli [1, 2]. There three major classes of receptors: µ (mu), κ (kappa), δ (delta), with subtypes within each receptor class [3]. Opioid receptors found in periaqueductal grey matter throughout spinal cord, as well nonneural sites such joint synovium intestinal mucosa [1,2].

参考文章(65)
Heat-related toxicity with the fentanyl transdermal patch. Journal of Pain and Symptom Management. ,vol. 16, pp. 277- 278 ,(1998) , 10.1016/S0885-3924(98)00100-6
Kathy A. Carter, Heat-associated increase in transdermal fentanyl absorption. American Journal of Health-system Pharmacy. ,vol. 60, pp. 191- 192 ,(2003) , 10.1093/AJHP/60.2.191
Kathy A Marquardt, R Steven Tharratt, Nabil A Musallam, Fentanyl remaining in a transdermal system following three days of continuous use. Annals of Pharmacotherapy. ,vol. 29, pp. 969- 971 ,(1995) , 10.1177/106002809502901001
Anthony R. Scialli, Goodman and Gilman's the pharmacologic basis of therapeutics Reproductive Toxicology. ,vol. 5, pp. 391- ,(1991) , 10.1016/0890-6238(91)90100-T
, Pharmacological Management of Persistent Pain in Older Persons Journal of the American Geriatrics Society. ,vol. 57, pp. 1331- ,(2009) , 10.1111/J.1532-5415.2009.02376.X
Frederick J Goldstein, Adjuncts to opioid therapy. The Journal of the American Osteopathic Association. ,vol. 102, ,(2002)
Mary Lou Perin, Chris Pasero, Problems with propoxyphene. American Journal of Nursing. ,vol. 100, pp. 22- ,(2000) , 10.1097/00000446-200006000-00025
Lukas Radbruch, Stefan Grond, Klaus A. Lehmann, A Risk-Benefit Assessment of Tramadol in the Management of Pain Drug Safety. ,vol. 15, pp. 8- 29 ,(1996) , 10.2165/00002018-199615010-00002
Daniel J. Clauw, Philip Mease, Robert H. Palmer, R. Michael Gendreau, Yong Wang, Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clinical Therapeutics. ,vol. 30, pp. 1988- 2004 ,(2008) , 10.1016/J.CLINTHERA.2008.11.009